Skip to main content Skip to main navigation menu Skip to site footer

Nodular anterior scleritis in systemic sclerosis: a case report



Abstract

Introduction: Scleritis is an inflammation of the sclera’s lining, characterized by cellular infiltration, collagen damage, and vascular changes. The incidence rate of scleritis accompanied by systemic disease generally is around 39% to 50%. Scleritis can be divided into two, namely anterior and posterior scleritis. Anterior scleritis can be divided into four, diffuse anterior scleritis, nodular anterior scleritis, necrotizing anterior scleritis with inflammation and without inflammation. One of the causes of nodular anterior scleritis is systemic sclerosis which is an autoimmune disease. Nodular anterior scleritis in systemic sclerosis is very rare, with an estimated prevalence rate of 4.4%.

Case Description: A man, 46 years old, complaining of red, watery, painful, and visible white membrane on his right eye since two weeks ago and was referred from an ophthalmologist with scleritis on his right eye. The patient had a history of asthma and cataract surgery. Physical examination showed right eye VA was 6/45 pinhole (PH) 6/18, conjunctival and scleral injection, nodule on superior conjunctiva with yellowish-white in color. Laboratory examination showed a clinical representation of autoimmune disease, consulted to the rheumatology division, and was diagnosed with systemic sclerosis. The patient has been prescribed corticosteroids and immunosuppressant’s for the therapy, the patient's eye condition improves after.

Conclusion: Systemic sclerosis with a presenting ophthalmologic complaint is a rare disease. This case illustrates that nodular anterior scleritis needs comprehensive intervention to seek the etiology and provide the treatment. This case has shown that nodular anterior scleritis with systemic sclerosis improved with corticosteroids and immunosuppressants, a typical treatment for autoimmune disease.

 

Keywords: nodular anterior scleritis systemic sclerosis autoimmune diseases corticosteroids

References

  1. Kowal?Bielecka O, Bielecki M, Kowal K. Recent advances in the diagnosis and treatment of systemic sclerosis. Pol Arch Intern Med. 2013;123(1–2):51–8.
  2. Wollheim FA. Classification of systemic sclerosis: Visions and reality. Rheumatology. 2005;44(10):1212–6.
  3. Tailor R, Gupta A, Herrick A, Kwartz J. Ocular Manifestations of Scleroderma. Surv Ophthalmol. 2009;54(2):292–304.
  4. American Academy of Ophthalmology. Scleritis. In: BCSC External Disease and Cornea - Section 8. San Fransisco: AAO; p. 174. (2016-2017).
  5. Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Clinical Characteristics of a Large Cohort of Patients with Scleritis and Episcleritis. Ophthalmology. 2012;119(1):43–50.
  6. Shah AA, Wigley FM. My approach to the treatment of scleroderma. Mayo Clin Proc. 2013;88(4):377–93.
  7. Nadashkevich O, Davis P, Fritzler MJ. A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit Int Med J Exp Clin Res. 2004;10(11): CR615-621.
  8. Sainz de la Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Scleritis Therapy. Ophthalmology. 2012;119(1):51–8.

How to Cite

Tridiyoga, K. P., Pramita, I. A. A., Juliari, I. G. A. M., Triningrat, A. A. M. P., Kusumadjaja, I. M. A., & Susila, N. N. (2021). Nodular anterior scleritis in systemic sclerosis: a case report. Intisari Sains Medis, 12(1), 147–151. https://doi.org/10.15562/ism.v12i1.901
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
Download Citation
Endnote/Zotero/Mendeley (RIS) BibTeX

HTML
107

Total
203

Share

Search Panel

Komang Putra Tridiyoga
Google Scholar
Pubmed
ISM Journal

Ida Ayu Ary Pramita
Google Scholar
Pubmed
ISM Journal

I Gusti Ayu Made Juliari
Google Scholar
Pubmed
ISM Journal

A. A Mas Putrawati Triningrat
Google Scholar
Pubmed
ISM Journal

I Made Agus Kusumadjaja
Google Scholar
Pubmed
ISM Journal

N.K Niti Susila
Google Scholar
Pubmed
ISM Journal